Tadalafil
- Product NDC
- 72603-783
- Requested package NDC
- 72603-783-01
- 11-digit product format
- 726030783
- Labeler code
- 72603
- Product ID
- 72603-783_57cf3737-88bc-699a-e063-6294a90a3223
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NorthStar Rx, LLC
- Application
- ANDA211298
- Marketing category
- ANDA
- Marketing start
- 2026-08-03
- Substance
- TADALAFIL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211298-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211298-001 | AB1 |
| A211298-002 | AB1 |
| A211298-003 | AB1 |
| A211298-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211298-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-001 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-002 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-003 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-004 | BX | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-001 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-002 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-003 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-004 | BX | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-001 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-002 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-003 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-004 | BX | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-001 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-002 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-003 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-004 | BX | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-001 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-002 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-003 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-004 | BX | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-001 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-002 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-003 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-004 | BX | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-001 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-002 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-003 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-004 | BX | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-001 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-002 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-003 | BX | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211298-004 | BX | 1 | d06236e962d9… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tadalafil
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TADALAFIL | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 742SXX0ICT | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a10d464a-6ea7-4e5a-befa-71eceacc5039 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Umedica Laboratories USA Inc. | 6caf3b55-9bf4-4355-9e25-8bf368943fdd | 2026-04-26 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | NIVAGEN PHARMACEUTICALS, INC. | ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a | 2025-12-09 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | e899da81-a28e-4a7e-a0e6-ed6d557c0bcd | 2025-04-08 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 828f0ee1-b9fc-4743-9394-fc086bcf5345 | 2025-04-08 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | a930511d-110e-4d2e-a4ca-df712f968b2d | 2024-04-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | 78b6659c-3a46-4998-9151-1a53afd83375 | 2024-04-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | 7dfb450b-4d39-40e7-b115-9a96023052a0 | 2023-11-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Status |
|---|---|---|---|---|---|
| 72603-783-01 | 72603078301 | 1000 TABLET, FILM COATED in 1 BOTTLE (72603-783-01) | 2026-08-03 | 0 | Current |